#

Eli Lilly

: 78
Eli Lilly will buy three vaccine developers. Photo: ChrisStock82/Shutterstock
News·
Eli Lilly will invest nearly $4 billion to buy three vaccine developers. Why would she do that?
Photo: X/NYSE
News·
Morning in New York: the situation is favorable for buying
Eli Lilly grew profits by 168% and raised its full-year forecast / Photo: Tada Images / Shutterstock
News·
Eli Lilly grew earnings 168% and raised its full-year guidance. What's up with the stock?
Eli Lilly to buy cancer drug developer Kelonia / Photo: Jonathan Weiss / Shutterstock.com
News·
Eli Lilly to buy oncology drug developer. What is it paying up to $7 billion for?
Prospects for a second round of Iran-US peace talks remain uncertain / Photo: somkanae sawatdinak / Shutterstock.com
News·
Morning in New York: Investors focus on escalation in the Middle East
The UAE is discussing with the US financial support in case of a prolonged conflict with Iran, WSJ has learned / Photo: Wael Hneini / unsplash
Review·
Highlights for the morning: UAE to ask for help, US intercepts Iranian ship, oil surges
Kailera Therapeutics Inc. has raised $625 million in an upsized IPO, marking the sector’s biggest U.S. listing since 2021 / Photo: Kailera
News·
+1
·
Kailera Therapeutics IPO: Shares of obesity drugmaker start trading
Novo Nordisk intends to implement OpenAI AI tools in all business processes by the end of 2026 / Photo: Below the Sky/Shutterstock.com
News·
"Superpower Charge": Novo Nordisk bets on OpenAI in confrontation with Eli Lilly
Forecasts for the expected size of the global market for obesity treatments have dropped about 30% to $100 billion by 2030, Noble Capital Markets writes / Photo: Shutterstock.com
Small Caps·
The obesity therapy market is changing. What smid-cap investors should know.
Brent crude oil rose in price by more than 3% at trading on March 17 / Photo: Shutterstock.com/Matt Gush
News·
Oil rose in price, but US stocks rose for the second straight day: results of the 18th day of the war
Pharmaceutical giant Eli Lilly sagged 1.1% in trading on March 17. Photo: Jonathan Weiss/Shutterstock
News·
Eli Lilly received a rare "sell" recommendation from analysts. Shares fell by 6%
Pharma is the most defensive sector amid conflict in the Middle East - UBS/Photo: shutterstock.com/Jonathan Weiss
News·
'Most defensive sector': UBS names stocks that can 'safely survive war'
Load more